Denmark-based biology company Octarine began producing psilocybin via a brewer’s yeast called Saccharomyces cerevisiae. While producing less than previous strains of bacteria and yeast this has proven to be the cheapest method. While losing about half of the production to psilocin conversion they are trying to work through those issues. They believe that the yeast processes are too similar to our stomach digestion and converting the psilocybin to psilocin. While still useful and may have a higher binding rate to Serotonin receptors, they are trying to make more psilocybin as that’s what they are testing. The reason for all of this is to make psilocybin more available to scientists and healthcare researchers. Traditionally, Psilocybin mushrooms are grown from spores, but this process is costly and labor-intensive under good practice methods. This is a step for companies to be able to collect more data and run more tests at a cheaper rate.
Related Articles
Leopoldo Salazar Viniegra: A Psychiatrist Ahead of His Time
Leopoldo Salazar Viniegra piloted one of the most forward thinking approaches to drug policy of the 21st century. In the 1930’s, he was one of Mexico’s leading psychiatrists and advocated a radical “social medicine” treatment approach. Alongside notable figures like...
Psilocybin in Science Before Prohibition: A Forgotten History
When we speak of this current moment, as psychedelics undergo an alleged “renaissance”, we often ignore a past that many people never learned. It’s a past in which psilocybin was a legitimate pharmaceutical, sold under a brand name and distributed by one of the...
Psilocybe ochraceocentrata – Hidden in Plain Sight
If you follow the world of magic mushroom microscopy, you've almost certainly encountered the spores of Natal Super Strength or Transkei. They're among the most popular specimens in the hobby, studied by enthusiasts and researchers alike. Like pretty much everyone...